Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Terns Pharmaceuticals Inc | 6,895,746 | 5,346,928 | -1,548,818 | $51.79M | $216.02M | 13.96% | +$164.23M |
| Cidara Therapeutics, Inc. | 1,311,425 | 956,670 | -354,755 | $125.58M | $211.32M | 13.66% | +$85.74M |
| Praxis Precision Medicines, Inc.(PRAX) | 198,895 | 328,895 | +130,000 | $10.54M | $96.94M | 6.27% | +$86.40M |
| Cogent Biosciences, Inc.(COGT) | 2,789,137 | 2,398,993 | -390,144 | $40.05M | $85.21M | 5.51% | +$45.16M |
| Trevi Therapeutics, Inc.(TRVI) | 5,094,668 | 5,094,668 | 0 | $46.62M | $63.79M | 4.12% | +$17.17M |
| Avadel Pharmaceuticals PLCADR | 2,684,109 | 2,684,109 | 0 | $40.99M | $57.84M | 3.74% | +$16.86M |
| Compass Therapeutics, Inc.(CMPX) | 9,545,466 | 9,545,466 | 0 | $33.41M | $51.26M | 3.31% | +$17.85M |
| Dyne Therapeutics, Inc.(DYN) | 2,614,960 | 2,614,960 | 0 | $33.08M | $51.15M | 3.31% | +$18.07M |
| ABIVAX Société AnonymeADS(ABVX) | 359,305 | 359,305 | 0 | $30.50M | $48.45M | 3.13% | +$17.95M |
| DBV Technologies S.A.ADS(DBVT) | 1,054,506 | 2,461,626 | +1,407,120 | $10.55M | $47.19M | 3.05% | +$36.64M |
| SAB Biotherapeutics, Inc.(SABS) | 11,420,000 | 11,420,000 | 0 | $22.95M | $42.71M | 2.76% | +$19.76M |
| Soleno Therapeutics Inc | 2,278,203 | 894,909 | -1,383,294 | $154.01M | $41.43M | 2.68% | -$112.57M |
| Bright Minds Biosciences Inc.(DRUG) | 501,617 | 501,617 | 0 | $30.43M | $39.15M | 2.53% | +$8.72M |
| Sinovac Biotech, Ltd.SHS(SVA) | 5,903,000 | 5,903,000 | 0 | $38.19M | $38.19M | 2.47% | $0 |
| Geron Corporation(GERN) | 27,225,292 | 27,225,292 | 0 | $37.30M | $35.94M | 2.32% | -$1.36M |
| Erasca, Inc.(ERAS) | 9,273,428 | 9,273,428 | 0 | $20.22M | $34.50M | 2.23% | +$14.28M |
| Zenas BioPharma, Inc.(ZBIO) | 1,183,260 | 853,495 | -329,765 | $26.27M | $30.99M | 2.00% | +$4.72M |
| Viridian Therapeutics, Inc.(VRDN) | 982,576 | 982,576 | 0 | $21.20M | $30.58M | 1.98% | +$9.37M |
| Aclaris Therapeutics, Inc.(ACRS) | 8,888,888 | 8,888,888 | 0 | $16.89M | $26.76M | 1.73% | +$9.87M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 3,921,568 | 4,246,568 | +325,000 | $11.76M | $26.03M | 1.68% | +$14.27M |
| Tango Therapeutics, Inc.(TNGX) | 776,699 | 2,154,780 | +1,378,081 | $6.52M | $19.09M | 1.23% | +$12.57M |
| Alto Neuroscience, Inc.(ANRO) | 0 | 1,035,551 | +1,035,551 | $0 | $18.43M | 1.19% | +$18.43M |
| LB Pharmaceuticals Inc(LBRX) | 800,000 | 800,000 | 0 | $12.63M | $17.81M | 1.15% | +$5.18M |
| Minerva Neurosciences, Inc.(NERV) | 0 | 4,322,747 | +4,322,747 | $0 | $17.38M | 1.12% | +$17.38M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 3,126,604 | 2,118,384 | -1,008,220 | $37.52M | $17.33M | 1.12% | -$20.19M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 2,234,566 | 2,234,566 | 0 | $16.47M | $17.21M | 1.11% | +$737.4K |
| Olema Pharmaceuticals, Inc.(OLMA) | 1,505,862 | 671,843 | -834,019 | $14.74M | $16.80M | 1.09% | +$2.05M |
| PepGen Inc.(PEPG) | 2,325,000 | 2,325,000 | 0 | $10.74M | $15.14M | 0.98% | +$4.39M |
| Design Therapeutics, Inc.(DSGN) | 0 | 1,612,903 | +1,612,903 | $0 | $15.13M | 0.98% | +$15.13M |
| Dianthus Therapeutics, Inc.(DNTH) | 353,998 | 353,998 | 0 | $13.93M | $14.59M | 0.94% | +$658.4K |
| MoonLake Immunotherapeutics(MLTX) | 0 | 1,000,000 | +1,000,000 | $0 | $13.18M | 0.85% | +$13.18M |
| CytomX Therapeutics, Inc.(CTMX) | 2,884,615 | 2,884,615 | 0 | $9.20M | $12.29M | 0.79% | +$3.09M |
| Unicycive Therapeutics, Inc.(UNCY) | 1,789,916 | 1,789,916 | 0 | $7.80M | $10.33M | 0.67% | +$2.52M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 1,350,000 | 1,350,000 | 0 | $7.96M | $10.19M | 0.66% | +$2.23M |
| Abeona Therapeutics Inc.(ABEO) | 1,842,751 | 1,842,751 | 0 | $9.73M | $9.71M | 0.63% | -$18.4K |
| Verastem, Inc.(VSTM) | 2,644,985 | 1,106,524 | -1,538,461 | $23.36M | $8.54M | 0.55% | -$14.81M |
| Silence Therapeutics plcADS(SLN) | 1,105,454 | 1,105,454 | 0 | $5.74M | $6.72M | 0.43% | +$983.9K |
| Monopar Therapeutics Inc.(MNPR) | 90,500 | 90,500 | 0 | $7.39M | $5.91M | 0.38% | -$1.48M |
| Surrozen, Inc.(SRZN) | 260,000 | 260,000 | 0 | $3.35M | $5.88M | 0.38% | +$2.53M |
| Palisade Bio, Inc.(PALI) | 0 | 2,293,578 | +2,293,578 | $0 | $5.39M | 0.35% | +$5.39M |
| Sera Prognostics, Inc.(SERA) | 1,650,440 | 1,650,440 | 0 | $5.05M | $4.87M | 0.31% | -$181.5K |
| Instil Bio, Inc.(TIL) | 292,743 | 292,743 | 0 | $5.23M | $3.22M | 0.21% | -$2.01M |
| Pasithea Therapeutics Corp.(KTTA) | 0 | 2,100,000 | +2,100,000 | $0 | $2.71M | 0.18% | +$2.71M |
| Tenax Therapeutics, Inc.(TENX) | 208,333 | 208,333 | 0 | $1.59M | $2.54M | 0.16% | +$954.2K |
| EnGene Holdings IncWARRANTS *W EXP 10/31/202 | 0 | 285,046 | +285,046 | $0 | $843.7K | 0.05% | +$843.7K |
| Bolt Therapeutics Inc | 176,064 | 72,414 | -103,650 | $936.7K | $396.0K | 0.03% | -$540.7K |
| Precision BioSciences, Inc.(DTIL) | 4,675 | 4,675 | 0 | $25.8K | $19.4K | 0.00% | -$6.4K |
| 89Bio Inc | 376,804 | 0 | -376,804 | $5.54M | $0 | — | -$5.54M |
| Akero Therapeutics Inc | 434,689 | 0 | -434,689 | $20.64M | $0 | — | -$20.64M |
| Astria Therapeutics Inc | 1,552,685 | 0 | -1,552,685 | $11.30M | $0 | — | -$11.30M |
| Delcath Systems, Inc.(DCTH) | 569,526 | 0 | -569,526 | $6.12M | $0 | — | -$6.12M |
| Rezolute, Inc.(RZLT) | 2,112,432 | 0 | -2,112,432 | $19.86M | $0 | — | -$19.86M |
| Tourmaline Bio Inc. | 591,882 | 0 | -591,882 | $28.31M | $0 | — | -$28.31M |
| Verona Pharma PLCADS | 1,393,432 | 0 | -1,393,432 | $148.69M | $0 | — | -$148.69M |